Cargando…
2’-Fluoro-2’-deoxycytidine inhibits murine norovirus replication and synergizes MPA, ribavirin and T705
Noroviruses are the main causative agents of acute viral gastroenteritis worldwide. However, no vaccine or specific antiviral treatment is available, imposing a heavy global health burden. The nucleoside analogue 2’-fluoro-2’-deoxycytidine (2’-FdC) has been reported to have broad antiviral activity....
Autores principales: | Yu, Peifa, Wang, Yining, Li, Yunlong, Li, Yang, Miao, Zhijiang, Peppelenbosch, Maikel P., Pan, Qiuwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414258/ https://www.ncbi.nlm.nih.gov/pubmed/32770483 http://dx.doi.org/10.1007/s00705-020-04759-4 |
Ejemplares similares
-
cGAS-STING effectively restricts murine norovirus infection but antagonizes the antiviral action of N-terminus of RIG-I in mouse macrophages
por: Yu, Peifa, et al.
Publicado: (2021) -
Nucleoside analogue 2’-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin
por: Qu, Changbo, et al.
Publicado: (2017) -
Ivermectin effectively inhibits hepatitis E virus replication, requiring the host nuclear transport protein importin α1
por: Li, Yunlong, et al.
Publicado: (2021) -
Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific
por: Xu, Lei, et al.
Publicado: (2014) -
Preclinical studies of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in pediatric brain tumors
por: Morfouace, Marie, et al.
Publicado: (2015)